Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1090220126Completed
Open-label, single-arm trial in soft tissue injury and Cardiac damage, sponsored by LTT Bio-Pharma Co., Ltd. Primary endpoint: efficiency of the differentiation method of cardiomyocytes and other cell types. Started May 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1090220126.